Physician

Albin John Abraham, MD

According to 2025 Medicare claims, Albin Abraham, MD (NPI: 1790917870) practices gastroenterology, with the plurality of this provider's patient population coming from Granville, NC. This provider's primary affiliated billing organization is GRANVILLE HEALTH INC. (NPI: 1336645720; TIN: 264073395) and primary practice location at 27565-2507.

Abraham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 353 traditional Medicare patients, billed 731 HCPCS/CPT codes, and received $69,746 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 3,245 prescription claims across 685 beneficiaries totaling $915,048 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 1 records totaling $58. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $140,095 to $915,048. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$73K$147K2017 Medicare payment: $20,051 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $48,900 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $121,398 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $121,524 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $146,606 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $125,246 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $109,365 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $69,746 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017141253$20,051
2018168457$48,900
20194001,286$121,398
20203831,244$121,524
20214591,481$146,606
20224751,263$125,246
20234311,075$109,365
2024353731$69,746

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$534K$1.1M2015 Drug cost: $140,095 (USD; Tot_Drug_Cst)2016 Drug cost: $230,407 (USD; Tot_Drug_Cst)2017 Drug cost: $299,118 (USD; Tot_Drug_Cst)2018 Drug cost: $205,899 (USD; Tot_Drug_Cst)2019 Drug cost: $346,748 (USD; Tot_Drug_Cst)2020 Drug cost: $419,934 (USD; Tot_Drug_Cst)2021 Drug cost: $547,440 (USD; Tot_Drug_Cst)2022 Drug cost: $836,036 (USD; Tot_Drug_Cst)2023 Drug cost: $1,067,710 (USD; Tot_Drug_Cst)2024 Drug cost: $915,048 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201550130$140,095
201651117$230,407
2017118281$299,118
2018215689$205,899
20193641,331$346,748
20204442,045$419,934
20216142,823$547,440
20226482,957$836,036
20236563,060$1,067,710
20246853,245$915,048

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare6565$168
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6060$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more222336$85
45380Biopsy of large bowel using a flexible endoscope2929$84
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope7173$59

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LinzessLinaclotide2089,428$169,297
CreonLipase/Protease/Amylase291,323$143,020
RinvoqUpadacitinib12354$98,258
Humira PenAdalimumab12336$84,941
Humira(Cf) PenAdalimumab11308$78,433

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$58BIOCOMPOSITES INC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Albin John Abraham, MD?

Tedicare shows public-source Medicare data for Albin John Abraham, MD (NPI 1790917870), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albin John Abraham, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Albin John Abraham, MD?

Albin John Abraham, MD is linked to GRANVILLE HEALTH INC. (billing NPI 1336645720) in the available physician profile data.

Does Albin John Abraham, MD have Open Payments data?

Albin John Abraham, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.